GCP
CLOV icon

GSA Capital Partners’s Clover Health Investments CLOV Stock Holding History

GSA Capital Partners’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$931K Sell
177,633
-257,801
-59% -$875K 0.06% 554
2026
Q1 		$766K Buy
435,434
+291,405
+202% +$632K 0.05% 622
2025
Q4 		$338K Sell
144,029
-32,528
-18% -$88.9K 0.03% 1102
2025
Q3 		$540K Sell
176,557
-132,120
-43% -$377K 0.05% 788
2025
Q2 		$861K Buy
308,677
+139,705
+83% +$459K 0.06% 560
2025
Q1 		$607K Sell
168,972
-40,943
-20% -$164K 0.05% 659
2024
Q4 		$661K Sell
209,915
-149,477
-42% -$534K 0.05% 699
2024
Q3 		$1.01M Sell
359,392
-553,674
-61% -$1.27M 0.08% 461
2024
Q2 		$1.12M Buy
913,066
+605,338
+197% +$543K 0.08% 436
2024
Q1 		$244K Buy
307,728
+56,138
+22% +$51.1K 0.02% 1316
2023
Q4 		$240K Sell
251,590
-26,099
-9% -$25.6K 0.02% 1232
2023
Q3 		$300K Sell
277,689
-1,210,119
-81% -$1.44M 0.03% 1079
2023
Q2 		$1.33M Buy
1,487,808
+1,101,443
+285% +$977K 0.13% 178
2023
Q1 		$327K Buy
386,365
+311,714
+418% +$341K 0.03% 976
2022
Q4 		$69K Buy
+74,651
New +$99.6K 0.01% 1337
2022
Q3 		– Sell
-72,032
Closed -$154K – 1559
2022
Q2 		$154K Buy
72,032
+32,080
+80% +$85.3K 0.02% 1135
2022
Q1 		$142K Buy
+39,952
New +$116K 0.02% 1240
2021
Q2 		– Sell
-26,375
Closed -$199K – 1346
2021
Q1 		$199K Buy
+26,375
New +$298K 0.03% 913

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GSA Capital Partners's CLOV Position: Q2 2026 in Review

GSA Capital Partners reduced its Clover Health Investments (CLOV) stake by 59% in Q2 2026, selling an estimated $875K and leaving 177,633 shares worth $931K. The position accounts for 0.06% of the portfolio, ranked #554.

GSA Capital Partners first reported a position in CLOV in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.33M in Q2 2023. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • GSA Capital Partners held 177,633 shares of Clover Health Investments worth $931K as of Q2 2026.
  • GSA Capital Partners sold 257,801 Clover Health Investments shares in Q2 2026, an estimated $875K.
  • Clover Health Investments made up 0.06% of GSA Capital Partners's portfolio in Q2 2026, its #554 holding.
  • GSA Capital Partners first reported a position in Clover Health Investments in Q1 2021 and has held it in 18 quarters since.
  • GSA Capital Partners's Clover Health Investments position peaked at $1.33M in Q2 2023.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.